本生药业（上海）有限公司

公司简介

Hangzhou Bensheng Pharmaceutical Corp. Ltd. was founded in April 2010 in the Hangzhou High-Tech Industrial Development Zone (Binjiang District). The company is a high-tech enterprise committed to new drug development and production, with a subsidiary in USA and a research center in Shanghai. It focuses on the development and production of novel anti-cancer and metabolic disease drugs with own intellectual property rights and utilizes its own development pattern to shorten the R&D timing, reduce costs, and develop first-class drugs with high efficacy and low toxicity. The company aims at IND filling with FDA. The company has selected a few novel small molecules in development stage, and will arrange clinical trials accordingly. The company cooperates with globally top ranked Contract Research Organization (CROs) to speed up the development program.The newly started and state of art Shanghai R&D center is located in Zhangjiang High Tech Park, Pudong, Shanghai. The Shanghai R&D center has position openings for research scientists, from Technician to Senior Scientist, in Molecular Biology, Oncology, Metabolic Disease, Pharmacokinetics, Pharmacodynamics, Bio-Analytic, Chem-Analytic, Natural Product Chemistry, Synthetic chemistry, and formulation. We also has position opening for Project Management, Pharmaceutical Information, Regulatory Affair, and Administration Associates.The company cooperates with top ranked Contract Research Organization (CROs) to speed up the development program.杭州本生药业有限公司是2010年4月在中国杭州国家高新技术产业（滨江）开发区注册设立的从事新药研发与生产的高新技术企业，设有美国分公司和上海研发中心。公司重点从事具有自主知识产权的、新颖的抗肿瘤药品与代谢疾病药品的研发与生产，并且开创全新的新药研发模式，缩短研发周期，降低研发成本，获取高效低毒的国际一流的新型药物。公司以美国FDA IND报批为目标，并且已经选择了一些新颖小分子进入研发阶段，后续将安排相应的临床试验。公司与国际一流的CRO公司进行合作，加速研发进程。公司新设立的上海研发中心坐落于上海市浦东新区张江高科技园区。上海研发中心在分子生物学、肿瘤学、代谢疾病学、药物动力学、药效学、生物分析、化学分析、天然产物化学、合成化学、制剂等领域将招聘从技术员到资深科学家的一系列研究科学家，除此之外，还招聘项目管理、药学情报、新药报批、行政助理等岗位。公司网站：www.benshengpharma.com